These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 36942271)

  • 1. Cannabinoid receptor 1 positive allosteric modulator (GAT229) attenuates cisplatin-induced neuropathic pain in mice.
    Bagher AM; Binmahfouz LS; Shaik RA; Eid BG
    Saudi Pharm J; 2023 Feb; 31(2):255-264. PubMed ID: 36942271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The In Vivo Effects of the CB
    Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM
    J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic Administration of Cannabinoid Agonists ACEA, AM1241, and CP55,940 Induce Sex-Specific Differences in Tolerance and Sex Hormone Changes in a Chemotherapy-Induced Peripheral Neuropathy.
    Barnes RC; Blanton H; Dancel CL; Castro-Piedras I; Rorabaugh BR; Morgan DJ; Guindon J
    J Pharmacol Exp Ther; 2024 Oct; 391(2):258-271. PubMed ID: 38936979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of the Cannabinoid CB1 Receptor's Positive Allosteric Modulator Binding Site through Mutagenesis Studies.
    Green HM; Fellner DMJ; Finlay DB; Furkert DP; Glass M
    Pharmaceuticals (Basel); 2024 Jan; 17(2):. PubMed ID: 38399369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric Cannabinoid Receptor 1 (CB1) Ligands Reduce Ocular Pain and Inflammation.
    Thapa D; Cairns EA; Szczesniak AM; Kulkarni PM; Straiker AJ; Thakur GA; Kelly MEM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cannabinoid CB1 Receptor-Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with No Psychoactive Effects.
    Ignatowska-Jankowska BM; Baillie GL; Kinsey S; Crowe M; Ghosh S; Owens RA; Damaj IM; Poklis J; Wiley JL; Zanda M; Zanato C; Greig IR; Lichtman AH; Ross RA
    Neuropsychopharmacology; 2015 Dec; 40(13):2948-59. PubMed ID: 26052038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantiomer-specific positive allosteric modulation of CB
    Mitjavila J; Yin D; Kulkarni PM; Zanato C; Thakur GA; Ross R; Greig I; Mackie K; Straiker A
    Pharmacol Res; 2018 Mar; 129():475-481. PubMed ID: 29158048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive allosteric modulation of the type 1 cannabinoid receptor reduces the signs and symptoms of Huntington's disease in the R6/2 mouse model.
    Laprairie RB; Bagher AM; Rourke JL; Zrein A; Cairns EA; Kelly MEM; Sinal CJ; Kulkarni PM; Thakur GA; Denovan-Wright EM
    Neuropharmacology; 2019 Jun; 151():1-12. PubMed ID: 30940536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meclizine and Metabotropic Glutamate Receptor Agonists Attenuate Severe Pain and Ca
    Shannonhouse J; Bernabucci M; Gomez R; Son H; Zhang Y; Ai CH; Ishida H; Kim YS
    J Neurosci; 2022 Aug; 42(31):6020-6037. PubMed ID: 35772967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive Allosteric Modulation of Cannabinoid Receptor Type 1 Suppresses Pathological Pain Without Producing Tolerance or Dependence.
    Slivicki RA; Xu Z; Kulkarni PM; Pertwee RG; Mackie K; Thakur GA; Hohmann AG
    Biol Psychiatry; 2018 Nov; 84(10):722-733. PubMed ID: 28823711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic peripherally-restricted cannabinoid suppresses chemotherapy-induced peripheral neuropathy pain symptoms by CB1 receptor activation.
    Mulpuri Y; Marty VN; Munier JJ; Mackie K; Schmidt BL; Seltzman HH; Spigelman I
    Neuropharmacology; 2018 Sep; 139():85-97. PubMed ID: 29981335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positive allosteric modulation of the cannabinoid CB
    Green HM; Manning JJ; Greig IR; Ross RA; Finlay DB; Glass M
    Br J Pharmacol; 2024 Oct; 181(19):3642-3662. PubMed ID: 38831545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD8+ T Cells and Endogenous IL-10 Are Required for Resolution of Chemotherapy-Induced Neuropathic Pain.
    Krukowski K; Eijkelkamp N; Laumet G; Hack CE; Li Y; Dougherty PM; Heijnen CJ; Kavelaars A
    J Neurosci; 2016 Oct; 36(43):11074-11083. PubMed ID: 27798187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy.
    Vera G; Cabezos PA; Martín MI; Abalo R
    Pharmacol Biochem Behav; 2013 Apr; 105():205-12. PubMed ID: 23454533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain.
    Li Y; North RY; Rhines LD; Tatsui CE; Rao G; Edwards DD; Cassidy RM; Harrison DS; Johansson CA; Zhang H; Dougherty PM
    J Neurosci; 2018 Jan; 38(5):1124-1136. PubMed ID: 29255002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral versus central mechanisms of the cannabinoid type 2 receptor agonist AM1710 in a mouse model of neuropathic pain.
    Wilkerson JL; Alberti LB; Kerwin AA; Ledent CA; Thakur GA; Makriyannis A; Milligan ED
    Brain Behav; 2020 Dec; 10(12):e01850. PubMed ID: 32977358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic cannabinoid receptor 2 activation reverses paclitaxel neuropathy without tolerance or cannabinoid receptor 1-dependent withdrawal.
    Deng L; Guindon J; Cornett BL; Makriyannis A; Mackie K; Hohmann AG
    Biol Psychiatry; 2015 Mar; 77(5):475-87. PubMed ID: 24853387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of CB1 and CB2 receptor agonists on responses of DRG neurons and dorsal horn neurons in neuropathic rats.
    Sagar DR; Kelly S; Millns PJ; O'Shaughnessey CT; Kendall DA; Chapman V
    Eur J Neurosci; 2005 Jul; 22(2):371-9. PubMed ID: 16045490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Antinociceptive and Antiinflammatory Properties of 3-furan-2-yl-N-p-tolyl-acrylamide, a Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptors in Mice.
    Bagdas D; Targowska-Duda KM; López JJ; Perez EG; Arias HR; Damaj MI
    Anesth Analg; 2015 Nov; 121(5):1369-77. PubMed ID: 26280585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evaluation of the CB
    Mustafa M; Donvito G; Moncayo L; Swafford A; Poklis J; Grauer R; Olszewska T; Ignatowska-Jankowska B; Kendall DA; Lu D; Lichtman AH
    Pharmacol Biochem Behav; 2020 Mar; 190():172840. PubMed ID: 31899221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.